Seasonale Sales Expected To Top $60 Mil. In First Full Year On Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr expects sales of Seasonale to reach at least $60 mil. in its fiscal 2005 based on the current run rate, CEO Bruce Downey said
You may also be interested in...
Role Reversal: Barr May Seek A Settlement To Thwart Generic Seasonale
Barr's request for patent re-issue was rejected by PTO, opening the door for Watson to launch generic Seasonale in September.
Role Reversal: Barr May Seek A Settlement To Thwart Generic Seasonale
Barr's request for patent re-issue was rejected by PTO, opening the door for Watson to launch generic Seasonale in September.
FDA Cites Barr Seasonale TV Ad For Misleading Risk Information
The direct-to-consumer ad fails to reveal that patients may experience breakthrough bleeding or spotting for up to a year, an FDA ad division letter states. The agency also says the risk information contained in the ad is obscured by the "compelling visuals."